Cargando…

A European myocardial (123)I-mIBG cross-calibration phantom study

AIM: Planar myocardial (123)I-meta-iodobenzylguanidine ((123)I-mIBG) scintigraphy is a highly reproducible technique. However, differences in collimator use are one of the most important factors that cause variation among institutions and studies in heart-to-mediastinum (H/M) ratio. Therefore, stand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verschure, Derk O., Poel, Edwin, Nakajima, Kenichi, Okuda, Koichi, van Eck-Smit, Berthe L.F., Somsen, G. Aernout, Verberne, Hein J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133137/ https://www.ncbi.nlm.nih.gov/pubmed/28120154 http://dx.doi.org/10.1007/s12350-017-0782-6

Ejemplares similares

Cardiac (123)I-mIBG Imaging in Heart Failure
por: Verschure, Derk O., et al.
Publicado: (2022)

Myocardial (123)I-mIBG scintigraphy in relation to markers of inflammation and long-term clinical outcome in patients with stable chronic heart failure
por: Verschure, Derk O., et al.
Publicado: (2016)

Polymorphism of SLC6A2 gene does not influence outcome of myocardial (123)I-mIBG scintigraphy in patients with chronic heart failure
por: Verschure, Derk O., et al.
Publicado: (2016)

Comparison of Taiwanese and European Calibration Factors for Heart-to-Mediastinum Ratio in Multicenter (123)I-mIBG Phantom Studies
por: Okuda, Koichi, et al.
Publicado: (2023)

Renal Function in Relation to Cardiac (123)I-MIBG Scintigraphy in Patients with Chronic Heart Failure
por: Verschure, Derk O., et al.
Publicado: (2012)

Vascular time-activity variation in patients undergoing (123)I-MIBG myocardial scintigraphy: implications for quantification of cardiac and mediastinal uptake
por: Verberne, Hein J., et al.
Publicado: (2011)

Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ((123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout
por: Verberne, Hein J., et al.
Publicado: (2009)

Cardiac sympathetic activity in chronic heart failure: cardiac (123)I-mIBG scintigraphy to improve patient selection for ICD implantation
por: Verschure, D. O., et al.
Publicado: (2016)

Standardization of (123)I-meta-iodobenzylguanidine myocardial sympathetic activity imaging: phantom calibration and clinical applications
por: Nakajima, Kenichi, et al.
Publicado: (2017)

The relation between cardiac (123)I-mIBG scintigraphy and functional response 1 year after CRT implantation
por: Verschure, D O, et al.
Publicado: (2020)

Role of cardiac (123)I-mIBG imaging in predicting arrhythmic events in stable chronic heart failure patients with an ICD
por: De Vincentis, Giuseppe, et al.
Publicado: (2018)

A simplified wall-based model for regional innervation/perfusion mismatch assessed by cardiac (123)I-mIBG and rest (99m)Tc-tetrofosmin SPECT to predict arrhythmic events in ischaemic heart failure( )
por: Verschure, Derk O, et al.
Publicado: (2021)

Cardiac sympathetic activity in hypertrophic cardiomyopathy and Tako-tsubo cardiomyopathy
por: Verschure, Derk O., et al.
Publicado: (2015)

Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma
por: Brady, Samuel L., et al.
Publicado: (2019)

Clinical performance and radiation dosimetry of no-carrier-added vs carrier-added (123)I-metaiodobenzylguanidine (MIBG) for the assessment of cardiac sympathetic nerve activity
por: Verberne, Hein J., et al.
Publicado: (2008)

Variations in (123)I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation
por: Verberne, Hein J., et al.
Publicado: (2007)

Misdiagnosis of Paraganglioma by (123)I-mIBG Without Stable Iodine Blockade of Thyroidal Radioiodine Uptake
por: Chen Cardenas, Stanley M, et al.
Publicado: (2020)

Comparison Between Diffusion‐Weighted MRI and (123)I‐mIBG Uptake in Primary High‐Risk Neuroblastoma
por: Privitera, Laura, et al.
Publicado: (2020)

Can early phase cardiac [(123)I]mIBG images be used to diagnose Lewy body disease?
por: Roberts, Gemma, et al.
Publicado: (2022)

(123)I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting ,method by an international panel
por: Lewington, V., et al.
Publicado: (2016)

The prognostic value of (123)I-mIBG SPECT cardiac imaging in heart failure patients: a systematic review
por: Pontico, Mariano, et al.
Publicado: (2021)

Persisting myocardial sympathetic dysfunction in takotsubo cardiomyopathy
por: Verberne, Hein J., et al.
Publicado: (2009)

Individualized (131)I-mIBG therapy in the management of refractory and relapsed neuroblastoma
por: George, Sally L., et al.
Publicado: (2016)

Objective comparison of lesion detectability in low and medium-energy collimator iodine-123 mIBG images using a channelized Hotelling observer
por: Gregory, Rebecca A, et al.
Publicado: (2017)

Nothing but NET: A review of norepinephrine transporter expression and efficacy of (131)I-mIBG therapy
por: Streby, Keri A, et al.
Publicado: (2015)

Using systematic reviews to identify research gaps - a case study: mIBG for the treatment of neuroblastoma in children
por: Wilson, Jayne, et al.
Publicado: (2013)

I-131 mIBG Scintigraphy Curie Versus SIOPEN Scoring: Prognostic Value in Stage 4 Neuroblastoma
por: Riaz, Saima, et al.
Publicado: (2018)

Cardiac Sympathetic Activity and Rhythm Control Following Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation—A Prospective (123)I-mIBG-SPECT/CT Imaging Study
por: Lange, Philipp S., et al.
Publicado: (2021)

The impact of acquisition time of planar cardiac (123)I-MIBG imaging on the late heart to mediastinum ratio
por: Dimitriu-Leen, Aukelien C., et al.
Publicado: (2015)

EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for (131)I mIBG treatment of neuroendocrine tumours
por: Gear, Jonathan, et al.
Publicado: (2020)

Improved outcome of (131)I-mIBG treatment through combination with external beam radiotherapy in the SK-N-SH mouse model of neuroblastoma
por: Corroyer-Dulmont, Aurélien, et al.
Publicado: (2017)

123-Iodine MIBG in the Assessment of Sympathetic Denervation in Ogilvie's Syndrome
por: Bhoil, Amit, et al.
Publicado: (2022)

CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake ((123/131)I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors
por: Grand-Guillaume, Joana, et al.
Publicado: (2023)

The prognostic value of estimated glomerular filtration rate, amino-terminal portion of the pro-hormone B-type natriuretic peptide and parameters of cardiopulmonary exercise testing in patients with chronic heart failure
por: Verberne, Hein J., et al.
Publicado: (2012)

Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations
por: Nakajima, Kenichi, et al.
Publicado: (2014)

The role of (131)I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma
por: Schoot, Reineke A., et al.
Publicado: (2013)

Phantom-Based Standardization Method for (123)I-metaiodobenzylguanidine Heart-to-Mediastinum Ratio Validated by D-SPECT Versus Anger Camera
por: Yamashita, Shozo, et al.
Publicado: (2023)

Myocardial (123)I-MIBG Uptake and Cardiovascular Autonomic Function in Parkinson's Disease
por: Katagiri, Akira, et al.
Publicado: (2015)

High-speed scanning of planar images showing (123)I-MIBG uptake using a whole-body CZT camera: a phantom and clinical study
por: Okano, Nanami, et al.
Publicado: (2019)

Cross calibration of (123)I-meta-iodobenzylguanidine heart-to-mediastinum ratio with D-SPECT planogram and Anger camera
por: Nakajima, Kenichi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_44hvp1p1sartv7mfoquusf9a20